Features of left ventricular remodeling in hypothyroidism and ischemic heart disease on the background of chronic systemic inflammation
Background. Thyroid dysfunction in modern medical science is regarded as one of the risk factors for cardiovascular diseases, unfortunately, unwittingly underestimated. It is known that even insignificant violations of thyroid function can be accompanied by the increased cardiometabolic risk. Hypothyroidism already on the early (subclinical) stage has a significant influence on formation and development of cardiovascular diseases. The results of large researches demonstrate that subclinical hypothyroidism is associated with increased risk for the development of ischemic heart disease, myocardial infarction and death rate from cardiovascular diseases. The purpose of this research is to study the structural and functional status of the left ventricular myocardium in hypothyroidism, ischemic heart disease and in comorbidity. Materials and methods. One hundred and forty clinical records were analyzed and 55 patients with hypothyroidism, ischemic heart disease and combined pathology were examined. They were divided into 3 groups: the first group — 81 patients with hypothyroidism, the second group — 67 individuals with ischemic heart disease, and the third group — 67 people with combination of hypothyroidism and ischemic heart disease. Control group included 20 persons aged 20 to 25 years. Results. It was found that myocardial hypertrophy developed in all groups of patients; the decrease of thyroid function is characterized by myocardial remodeling with the development of eccentric hypertrophy, with the progression of systolic dysfunction in case of comorbidity. A direct correlation was found between reduced ejection fraction and higher levels of interleukin8. Conclusions. Activation of chronic systemic inflammation is more significant in comorbidity, with negative prognostic influence on the state of the cardiovascular system. The decline of thyroid function results in the development of left myocardial hypertrophy with subsequent changes in cardiac geometry towards eccentric remodeling. Hypothyroidism is characterized by impaired central hemodynamics; manifestations of systolic dysfunction are increased in combination of thyroid pathology and ischemic heart disease. Activation of chronic systemic inflammation is more significant in comorbidity, with negative prognostic influence on the state of the cardiovascular system.
Full Text:PDF (Українська)
Mitchenko OI, Logvinenko AO, Romanov VYu. The optimisation of lipid and carbohydrate exchange correction in patients with metabolic syndrome and thyroid dysfunction. Ukrainian Journal of Cardiology. 2010;(1):73-80. (in Ukrainian).
Gallo D, Piantanida E, Pariani N, et al. P134 Masked hypertension in a cohort of newly diagnosed hypothyroid patients. In: 38th Annual Meeting of the European Thyroid Association. Eur Thyroid J. 2014;3(Suppl 1):73-226. doi: 10.1159/000365244.
Chcl KI, Kim BH. P132 The impact of subclinical thyroid dysfunction on coronary vasospasm in patients without associated cardiovascular risk factors. In: 38th Annual Meeting of the European Thyroid Association. Eur Thyroid J. 2014;3(Suppl 1):73-226. doi: 10.1159/000365244.
Starkova NT, Kandror VI, Babichev VN, et al., authors; Starkova NT, editor. Klinicheskaia endokrinologiia: rukovodstvo [Clinical endocrinology: a guide]. 3rd ed. SPb: Piter; 2002. 576 p. (in Russian).
Hak AE, Pols HA, Visser TJ , Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam study. Ann Intern Med. 2000 Feb 15;132(4):270-8.
Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Sublinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males bellow 50 years. Clin Endocrinol (Oxf). 2004 Aug;61(2):232-8. doi: 10.1111/j.1365-2265.2004.02088.x.
Fes'kova AA, Dobrysheva ES. The value of subclinical hypothyroidism in the pathogenesis of diseases of the cardiovascular system: review of literature. Molodoj uсenyj. 2014;(17):207-210. (in Russian).
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
Volkova А, Dora S, Berkovich O, Grineva E, Dygun O. P148 Predictive risk model of severe coronary atherosclerosis in heart ischemic disease patients with subclinical hypothyroidism. In: 38th Annual Meeting of the European Thyroid Association. Eur Thyroid J. 2014;3(Suppl 1):73-226. doi: 10.1159/000365244.
Fernandez-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab. 2006 Sep;91(9):3337-43. doi: 10.1210/jc.2006-0841.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2019